Immunity and Inflammation in Epilepsy

  1. Eleonora Aronica3,4,5
  1. 1Department of Neuroscience, IRCSS-Istituto di Ricerche Farmacologiche “Mario Negri,” 20156 Milano, Italy
  2. 2Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford OX3 9DU, United Kingdom
  3. 3Department of (Neuro)Pathology, Academic Medical Center, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
  4. 4Department of (Neuro)Pathology, Swammerdam Institute for Life Sciences, Center for Neuroscience, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands
  5. 5SEIN-Stichting Epilepsie Instellingen Nederland, Heemstede 2103 SW, The Netherlands
  1. Correspondence: annamaria.vezzani{at}marionegri.it

Abstract

This review reports the available evidence on the activation of the innate and adaptive branches of the immune system and the related inflammatory processes in epileptic disorders and the putative pathogenic role of inflammatory processes developing in the brain, as indicated by evidence from experimental and clinical research. Indeed, there is increasing knowledge supporting a role of specific inflammatory mediators and immune cells in the generation and recurrence of epileptic seizures, as well as in the associated neuropathology and comorbidities. Major challenges in this field remain: a better understanding of the key inflammatory pathogenic pathways activated in chronic epilepsy and during epileptogenesis, and how to counteract them efficiently without altering the homeostatic tissue repair function of inflammation. The relevance of this information for developing novel therapies will be highlighted.

Also in this Collection

    | Table of Contents

    Richard Sever interviews Joan Brugge